Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Imperial Brands plc

Start price
Target price
Perf. (%)
€23.39
14.01.20
-
04.11.21
-20.03%
05.11.21

AlleAktien 
14.01.20 50%
buy
Lloyds Banking Group

Start price
Target price
Perf. (%)
€0.73
20.01.17
€1.00
04.11.21
-22.83%
05.11.21

dietmar99 
14.08.19 50%
buy
Lloyds Banking Group

Start price
Target price
Perf. (%)
€0.73
20.01.17
€1.00
04.11.21
-22.83%
05.11.21

dietmar99 
14.08.19 50%
buy
British American Tobacco PLC

Start price
Target price
Perf. (%)
€28.13
07.01.19
€53.00
04.11.21
6.29%
05.11.21

Very high dividend yield expected
Very capable Management
Very good company culture
Strong uniques
DrMabuse 
12.08.19 70%
buy
British American Tobacco PLC

Start price
Target price
Perf. (%)
€28.13
07.01.19
€53.00
04.11.21
6.29%
05.11.21

Very high dividend yield expected
Very capable Management
Very good company culture
Strong uniques
DrMabuse 
12.08.19 70%
sell
Rio Tinto plc

Start price
Target price
Perf. (%)
€69.91
04.03.21
€65.00
04.03.22
-23.19%
03.11.21

Could be worthwhile Investment >10% per year
Medium risks for its business
Market Leader or Top 3
Sustainability is little important
Snowman 
04.03.21 50%
sell
Rio Tinto plc

Start price
Target price
Perf. (%)
€69.91
04.03.21
€65.00
04.03.22
-23.19%
03.11.21

Could be worthwhile Investment >10% per year
Medium risks for its business
Market Leader or Top 3
Sustainability is little important
Snowman 
04.03.21 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€4.48
14.09.21
-
14.09.22
-4.46%
19.09.21

Risky Investment
thomasw 
14.09.21 50%
buy
Vodafone Group

Start price
Target price
Perf. (%)
€1.56
23.04.21
-
23.04.22
-12.35%
17.09.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Increased challenges to pay loans and raise capital
NightTrain 
23.04.21 50%
buy
Vodafone Group

Start price
Target price
Perf. (%)
€1.56
23.04.21
-
23.04.22
-12.35%
17.09.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Increased challenges to pay loans and raise capital
NightTrain 
23.04.21 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€11.72
14.09.20
€21.00
04.11.21
46.82%
02.08.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
cbetz100 
14.09.20 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€11.72
14.09.20
€21.00
04.11.21
46.82%
02.08.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
cbetz100 
14.09.20 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€11.72
14.09.20
€21.00
04.11.21
46.82%
02.08.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
cbetz100 
14.09.20 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€14.86
01.01.21
-
01.01.22
15.80%
12.07.21

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
Revenue decline/stagnation expected
Schmiedseppe 
01.01.21 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€14.86
01.01.21
-
01.01.22
15.80%
12.07.21

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
Revenue decline/stagnation expected
Schmiedseppe 
01.01.21 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€14.86
01.01.21
-
01.01.22
15.80%
12.07.21

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
Revenue decline/stagnation expected
Schmiedseppe 
01.01.21 50%
buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
0.47%
05.07.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Gilbert 
17.06.21 50%
buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
0.47%
05.07.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Gilbert 
17.06.21 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€5.70
18.10.20
€2.00
04.11.21
-35.79%
26.06.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
mixitrader 
18.10.20 50%
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€80.50
24.03.20
€180.00
04.11.21
127.33%
24.06.21

Subdi 
24.03.20 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
20.08.20
€105.50
04.11.21
1.68%
14.06.21

Future proof or reliable business model
Small cyclical dependencies
Known brand
gerihouse 
20.08.20 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€95.39
20.08.20
€105.50
04.11.21
1.68%
14.06.21

Future proof or reliable business model
Small cyclical dependencies
Known brand
gerihouse 
20.08.20 50%
sell
AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

Subdi 
22.09.20 50%
sell
AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

Subdi 
22.09.20 50%
buy
Shell plc

Start price
Target price
Perf. (%)
€15.50
05.01.21
€20.00
05.01.22
2.26%
26.05.21

Top 10 in its market
Well known brand
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Snowman 
05.01.21 70%